CastleKnight Management LP Increases Stake in Teladoc Health, Inc. (NYSE:TDOC)

CastleKnight Management LP lifted its holdings in Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 47.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 209,800 shares of the health services provider's stock after buying an additional 67,100 shares during the quarter. CastleKnight Management LP owned approximately 0.12% of Teladoc Health worth $1,907,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Versant Capital Management Inc increased its stake in Teladoc Health by 313.8% during the 4th quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider's stock valued at $29,000 after purchasing an additional 2,441 shares in the last quarter. Whipplewood Advisors LLC bought a new position in Teladoc Health during the fourth quarter valued at approximately $29,000. Lindbrook Capital LLC grew its stake in shares of Teladoc Health by 78.9% during the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock valued at $33,000 after purchasing an additional 1,612 shares during the period. Sterling Capital Management LLC raised its position in Teladoc Health by 776.7% in the fourth quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider's stock worth $42,000 after acquiring an additional 4,101 shares during the period. Finally, Pilgrim Partners Asia Pte Ltd purchased a new position in shares of Teladoc Health during the 4th quarter worth $60,000. Hedge funds and other institutional investors own 76.82% of the company's stock.

Insider Activity

In other Teladoc Health news, insider Adam C. Vandervoort sold 11,011 shares of the stock in a transaction dated Thursday, March 20th. The shares were sold at an average price of $8.42, for a total value of $92,712.62. Following the completion of the sale, the insider now owns 64,308 shares in the company, valued at approximately $541,473.36. This represents a 14.62 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.58% of the company's stock.

Wall Street Analysts Forecast Growth

TDOC has been the subject of several analyst reports. Royal Bank of Canada increased their target price on shares of Teladoc Health from $11.00 to $12.00 and gave the stock an "outperform" rating in a report on Friday, January 24th. Stifel Nicolaus lowered their price target on Teladoc Health from $9.00 to $8.00 and set a "hold" rating on the stock in a report on Thursday, May 1st. Jefferies Financial Group reduced their price objective on shares of Teladoc Health from $10.00 to $8.00 and set a "hold" rating on the stock in a research report on Monday, April 21st. Canaccord Genuity Group cut their target price on shares of Teladoc Health from $14.00 to $12.00 and set a "buy" rating for the company in a research note on Thursday, May 1st. Finally, Bank of America reduced their target price on Teladoc Health from $9.50 to $8.00 and set a "neutral" rating on the stock in a report on Friday, April 11th. Eleven equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $9.81.

Teladoc Health Stock Performance

Shares of TDOC opened at $7.15 on Tuesday. The stock has a 50-day moving average of $7.94 and a two-hundred day moving average of $9.47. The stock has a market cap of $1.25 billion, a P/E ratio of -1.24 and a beta of 1.82. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. Teladoc Health, Inc. has a one year low of $6.35 and a one year high of $15.21.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The company had revenue of $640.49 million during the quarter, compared to analysts' expectations of $639.44 million. As a group, research analysts predict that Teladoc Health, Inc. will post -1.16 EPS for the current year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.